“…DT can define specific axonal trajectories as the basis of pathwayactivation models to provide better anatomical/electrical volume conductor estimations to evaluate the strength and coverage of electric field covering DBS targets (Gunalan et al, 2018). As such, DT helped strategize the best direct or indirect DBS target by delineating and segmenting STN-cortical (Chen et al, 2018;Gunalan et al, 2018), pallido-cortical (Middlebrooks et al, 2018), pedunculopontine (Raghu et al, 2021), and cortico-cerebellar pathways (Strotzer et al, 2019;Coenen et al, 2020) to mitigate PD-related motor symptoms and minimize unwanted side effects, such as depression and impaired cognition (Combs et al, 2015;Irmen et al, 2020).…”